An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Clinical trial NCT07620392 · RECRUITING
Trial details
- NCT number
- NCT07620392
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-03
- Primary completion
- 2033-07-08
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.